|
|
|
| Clinical Efficacy of Supportive Expressive Group Psychological Intervention Combined with Paliperidone Palmitate in the Treatment of Acute First-Episode Schizophrenia |
| ZHAO Wen-qing |
| Baoji Rehabilitation Hospital,Baoji Shaanxi 721000 |
|
|
|
|
Abstract 【Objective】 To explore the clinical effect of supportive expressive group psychological intervention combined with paliperidone palmitate in the treatment of acute first-episode schizophrenia. 【Methods】 The clinical data of 98 patients with acute first-episode schizophrenia treated in our hospital from January 2019 to February 2021 were analyzed retrospectively. According to different treatment methods, they were divided into observation group and control group, with 49 cases in each group. The control group was treated with paliperidone palmitate sustained-release tablets, and the observation group was given supportive expressive group psychological intervention on the basis of the control group. The scores of positive and negative emotional state scale (PANAS), social function deficiency screening scale (SDSS) and quality of life scale for patients with schizophrenia (SQLS) were compared between the two groups before and after treatment. 【Results】 After one month and three months of treatment, the positive emotion score of the two groups was higher than that before treatment, and the negative emotion score was lower than that before treatment. There was significant difference between the two groups after three months of treatment and one month of treatment, as well as between the two groups (all P<0.05); The social function defect score of the two groups was lower than that before treatment, and there was significant difference between the two groups after 3 months of treatment and 1 month of treatment, as well as between the two groups (all P<0.05); The scores of motivation and energy, psychosocial, symptoms and side effects of the two groups were lower than those before treatment, and there were significant differences between the two groups after 3 months of treatment and 1 month of treatment, as well as between the two groups (all P<0.05). 【Conclusion】 Supportive expressive group psychological intervention combined with paliperidone palmitate can better improve the emotional state, restore the social function and improve the quality of life of patients with acute first-episode schizophrenia.
|
|
Received: 22 January 2021
|
|
|
|
|
|
[1] VITA A, BARLATI S. Recovery from schizophrenia:is it possible?[J].Curr Opin Psychiatry,2018,31(3):246-255.
[2] MÜLLER N.Inflammation in schizophrenia:pathogenetic aspects and therapeutic considerations[J].Schizophr Bull,2018,20(5):973-982.
[3] 王继红,张文静,许立红.帕利哌酮对首次发作精神分裂症患者精神病症状及生活质量的影响[J].医药导报,2018,37(7):852-855.
[4] 肖林,谢亚菲.棕榈酸帕利哌酮治疗依从性的相关因素及其对精神分裂症患者复发的影响[J].实用药物与临床,2019,22(3):282-285.
[5] 磨丽莉,潘巧淑,周芳珍,等.运动治疗联合心理护理对慢性精神分裂症病人康复和生活质量的影响[J].护理研究,2019,33(17):362-363.
[6] 常晓娟,杨小龙,高成阁.利培酮与舍曲林联合对精神分裂症阴性症状患者sTNFRs及神经电生理特征的影响[J].医学临床研究,2020,37(1):15-17.
[7] 季曹珺,粟幼嵩,王勇,等.住院精神分裂症患者棕榈酸帕利哌酮注射液使用情况调查[J].临床精神医学杂志,2018,28(1):26-28.
[8] 王志满,陈薇,贺英,等.绘画心理技术训练辅助抗精神病药物对精神分裂症康复期患者恢复效果的影响[J].中国医师杂志,2020,22(11):1677-1680.
[9] 李志武,李斌,何燕,等.社区综合干预对精神分裂症患者康复、社会功能及社会经济效益影响的研究[J].国际精神病学杂志,2018,45(5):83-86.
[10] 仪玉伟,李雪霓,魏时懿,等.团体心理治疗对恢复期精神分裂症患者生活质量及社会功能影响研究[J].国际精神病学杂志,2018,45(5):87-90.
[11] 李瑛,孙波,王新.结构式团体心理干预在经肝动脉化疗栓塞术治疗的原发性肝癌患者应用效果研究[J].实用肝脏病杂志,2018,21(3):161-162.
[12] 孙勤,杨秀梅.支持性心理干预对初诊慢性乙肝患者希望水平及应对方式的影响[J].医学临床研究,2019,36(5):997-1000. |
|
|
|
2022, Vol. 39 
